Food and Drug Administration

FDA Approves GE Brain Imaging Tool for Alzheimer’s
FDA Approves GE Brain Imaging Tool for Alzheimer’s
FDA Approves GE Brain Imaging Tool for Alzheimer’s
WASHINGTON (AP) — The Food and Drug Administration has approved a radioactive imaging chemical from General Electric to help screen for Alzheimer's disease. The drug, Vizamyl, is an injection of radioactive material designed to highlight abnormal brain plaque in medical imaging scans...